VVirtest Technologies
Virtest Technologies is a Barcelona-based medtech spin-off of Universitat Pompeu Fabra's PhySense/BCN-MedTech group that builds patient-specific cardiac "virtual twins" and computational flow simulations for planning minimally invasive structural heart procedures. Its main product, VIDAA, is a cloud platform for Left Atrial Appendage Occlusion (LAAO) that lets clinicians virtually implant and test occluder devices before surgery, complemented by ARIDAA, an augmented-reality visualisation app, plus device-testing and virtual-training services. Incorporated in October 2024 after ~€2.1M of research grants, it raised a €800K seed round in October 2025 led by Grow Venture Partners with Fons FITA to pursue CE marking.
SectorsHealthtech & Bio, Medtech, AI & Data, Digital Twins, Simulation Software, Cardiovascular
Start-up MapHealthtech & Bio › Clinical software & health data
Founders
A
Ainhoa M. Aguado
Co-founder & Software Team Lead
A
Andy L. Olivares
Co-founder
J
Jordi Mill
CEO & Co-founder
O
Oscar Camara
Co-founder
Global models 5
HHeartFlow
United States · www.heartflow.com ↗
Builds patient-specific computational models of the heart from CT to simulate blood flow and plan procedures, and sells the analysis to hospitals per case, as VIDAA does.
~$930MComparable
CCleerly
United States · cleerlyhealth.com ↗
A cloud platform that turns cardiac CT into patient-specific 3D models for clinicians to plan treatment, sold per scan to hospitals and imaging centres.
~$390MComparable
EElucid
United States · elucid.com ↗
Uses cardiac CT to build patient-specific models of plaque and simulated flow for heart treatment decisions, delivered as SaaS to clinicians.
~$80MComparable
FFEops
Belgium · www.feops.com ↗
The closest match: its HEARTguide cloud platform uses patient-specific computer simulation to virtually implant LAAO and TAVI devices before structural heart procedures (acquired by Materialise in 2024).
~$20MComparable
IinHEART
France · www.inheart.fr ↗
An academic spin-off that builds 3D digital twins of the heart from imaging to plan minimally invasive heart procedures (ablation), sold per case to hospitals.
~$15MComparable
In the same niche 53 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 1
Open as list →
Funding rounds 1
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-10-23 | Seed | €800K | Grow Venture Partners |
News 4
Open as list →| Published | Article |
|---|---|
| 2025-12-05 |
CSI Focus LAA 2025: Live case and talk ↗
VIRTEST (press release)
2025-12-05 |
| 2025-10-23 |
Virtest Technologies secures €800,000 seed funding led by Grow Venture Partners to transform cardiac surgery through AI ↗
Capital-Riesgo.es
2025-10-23 |
| 2025-09-24 |
RIICE Focus 2025 ↗
VIRTEST (press release)
2025-09-24 |
| 2024-12-02 |
VirTest, la nueva spin-off de la UPF que impulsa la medicina personalizada con gemelos digitales ↗
Salud35 (ConSalud)
2024-12-02 |